Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist

Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist

US Patent 11472811 · Granted Oct 18, 2022

Estimated economic value: $69,758,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist2025
Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist2025
Metal mesh touch screen and method for manufacturing metal mesh touch screen2024
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer2022
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer2022
Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases2022
Test device and method for top-of-the-line corrosion of high-temperature high-pr2022
Mobile device comprising stylus pen and operation method therefor2022
Treatment cancers using a combination comprising PARP inhibitors2021
Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, a2021
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleam2021
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleam2021